ERS-EACTS-ESTS-ESTRO Guidelines for the management of Malignant Pleural Mesothelioma patients

Previously considered as a rare tumor, malignant pleural mesothelioma (MPM) has become a very important public health issue. MPM is a tumor with a poor survival and its diagnosis may be difficult because of differential diagnosis such as pleural benign disease induced by asbestos exposure or pleural metastasis of adenocarcinoma. Management of patients with MPM also remains complicated because they are often referred for evaluation late in the evolution of the disease. The aim of this Task Force is therefore to provide clinicians with new concise, up-to-dated clinical practice guidelines on management of MPM.